Abstract
In this chapter, we discuss pharmacological and administrative approaches to the treatment of posttraumatic stress disorder (PTSD) in the military population, including treatment of comorbid substance use disorders and acting as a liaison with command. Current evidence and clinical practice guidelines support the use of SSRIs, specifically sertraline, as first-line treatment for PTSD, as well as prazosin for PTSD-associated sleep disturbances and nightmares. Benzodiazepines and non-benzodiazepine hypnotics should be avoided as they have been shown to cause harm. Administrative policies unique to the military can also pose a challenge to appropriate care and are outlined below.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2014
Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety. 2011;28:596–606.
Martin J, Ghahramanlou-Holloway M, Lou K, Tucciarone P. A comparative review of U.S. Military and civilian suicide behavior: implications for OEF/OIF suicide prevention efforts. J Ment Health Couns. 2009;31(2):101–18.
Kellermann AL, Rivara FP, Somes G, et al. Suicide in the home in relation to gun ownership. N Engl J Med. 1992;327(7):467–72.
Reger MA, et al. Risk of suicide among US military service members following operation enduring freedom or operation Iraqi freedom deployment and separation from the US military. JAMA Psychiatry. 2015. doi:10.1001/jamapsychiatry.2014.3195.
Rice TR, Sher L. Suicidal behavior in war veterans. Expert Rev Neurother. 2012;12:611–24.
Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of Posttraumatic stress. Washington, DC: VA/DoD; 2010.
Rapaport MH, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry. 2002;63:59–65.
Londborg PD, Hegel MT, Goldstein S, et al. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Clin Psychiatry. 2001;62:325–31.
Kung S, Espinel Z, Lapid MI. Treatment of nightmares with prazosin: a systematic review. Mayo Clinic Proc. 2012;87:890–900.
Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160:371–3.
Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with Posttraumatic stress disorder. Biol Psychiatry. 2007;61:928–34.
Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170(9):1003–10.
Viola J, Ditzler T, Batzer W, et al. Pharmacological management of Posttraumatic stress disorder: clinical summary of a five-year retrospective study, 1990–1995. Mil Med. 1997;162:616–9.
Hart G, Panayi MC, Harris JA, Westbrook RF. Benzodiazepine treatment can impair or spare extinction, depending on when it is given. Behav Res Ther. 2014;56:22–9.
Kosten TR, Fontana A, Sernyak MJ, Rosenheck R. Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse. J Nerv Ment Dis. 2000;188:454–9.
Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of substance use disorders. Washington, DC: VA/DoD; 2009.
Defense Health Agency Pharmacy Operations Division. Pharmacy operations division. http://www.health.mil/About-MHS/Defense-Health-Agency/Healthcare-Operations/Pharmacy-Division. 2015. Accessed: 20. Dec. 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Richardson, R., Rumbaugh, W., Zembrzuska, H. (2015). The Multifactorial Approach to PTSD in the Active Duty Military Population. In: Ritchie, E. (eds) Posttraumatic Stress Disorder and Related Diseases in Combat Veterans. Springer, Cham. https://doi.org/10.1007/978-3-319-22985-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-22985-0_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22984-3
Online ISBN: 978-3-319-22985-0
eBook Packages: MedicineMedicine (R0)